Thomas R Cannell Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas R Cannell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas R Cannell. Thomas R Cannell is a Chief Commercial Officer in Orexigen Therapeutics, Inc. ($OREX) and a EVP, Chief Commercial Officer in Orexigen Therapeutics, Inc. ($OREX) and a EVP, COO, Pres Global Com Prod in Orexigen Therapeutics, Inc. ($OREX) and a President and CEO in Sesen Bio, Inc. ($EBIO).
Address: 3344 N. TORREY PINES COURT SUITE 200 LA JOLLA 92037 CA
Companies in which Thomas R Cannell is an Insider
Orexigen Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Thomas R Cannell: EVP, COO, Pres Global Com Prod, EVP, Chief Commercial Officer, Chief Commercial Officer
Holdings: 3,882 shares
Current Value: $17,780
Latest Transaction: Oct 17 2017
$OREX Market Capitalization: $70.30M
$OREX Previous Close: $4.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sesen Bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Thomas R Cannell: President and CEO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 23 2021
$SESN Market Capitalization: $34.48M
$SESN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Thomas R Cannell
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2021 | SESN | Sesen Bio, Inc. | Cannell Thomas R | President and CEO | Option Exercise | A | 3.17 | 2,000,000 | 6,340,000 | 2,000,000 | |
| Feb 18 2020 | SESN | Sesen Bio, Inc. | Cannell Thomas R | President and CEO | Option Exercise | A | 0.89 | 1,450,000 | 1,292,095 | 1,450,000 | |
| Feb 25 2019 | EBIO | Sesen Bio, Inc. | Cannell Thomas R | President and CEO | Option Exercise | A | 0.83 | 1,000,000 | 828,500 | 1,000,000 | |
| Oct 17 2017 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, COO, Pres Glob ... | Option Exercise | A | 0.00 | 91,200 | 0 | 91,200 | |
| Jun 02 2017 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, COO, Pres Glob ... | Grant | A | 1.55 | 2,119 | 3,284 | 3,882 | 1.8 K to 3.9 K (+120.19 %) |
| Feb 07 2017 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, COO, Pres Glob ... | Option Exercise | A | 15.00 | 72,000 | 1,080,000 | 144,000 | |
| Feb 07 2017 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, COO, Pres Glob ... | Option Exercise | A | 4.10 | 144,000 | 590,400 | 144,000 |